{"data":[{"accessionNo":"0000921895-26-002901","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-30","reportingPerson":"Bigger Michael","reportingCik":null,"personType":"IN","sharesOwned":414064,"percentOfClass":8.36,"filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-002901","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-30","reportingPerson":"Bigger Capital Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":242832,"percentOfClass":4.9,"filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-002901","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-30","reportingPerson":"BIGGER CAPITAL FUND L P","reportingCik":null,"personType":"PN","sharesOwned":242832,"percentOfClass":4.9,"filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-002901","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-30","reportingPerson":"District 2 Capital Fund LP","reportingCik":null,"personType":"PN","sharesOwned":171232,"percentOfClass":3.46,"filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-002901","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-30","reportingPerson":"District 2 Holdings LLC","reportingCik":null,"personType":"OO","sharesOwned":171232,"percentOfClass":3.46,"filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-002901","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-30","reportingPerson":"District 2 GP LLC","reportingCik":null,"personType":"OO","sharesOwned":171232,"percentOfClass":3.46,"filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-002901","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-09-30","reportingPerson":"District 2 Capital LP","reportingCik":null,"personType":"PN","sharesOwned":171232,"percentOfClass":3.46,"filedAt":"2026-11-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001493152-26-026642","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-05-27","reportingPerson":"Kyri K. Van Hoose","reportingCik":"0001860885","personType":"IN","sharesOwned":384352,"percentOfClass":9,"filedAt":"2026-06-01","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001213900-26-055876","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Intracoastal Capital LLC","reportingCik":null,"personType":"OO","sharesOwned":211246,"percentOfClass":4.99,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001213900-26-055876","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Daniel B. Asher","reportingCik":null,"personType":"HC,IN","sharesOwned":211246,"percentOfClass":4.99,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001213900-26-055876","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"249845504","securityClass":"Common stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Mitchell P. Kopin","reportingCik":null,"personType":"HC,IN","sharesOwned":211246,"percentOfClass":4.99,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-001059","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"84841L407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Bigger Capital Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":75200,"percentOfClass":1.87,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-001059","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"84841L407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Bigger Michael","reportingCik":null,"personType":"IN","sharesOwned":75200,"percentOfClass":1.87,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-001059","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"84841L407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"BIGGER CAPITAL FUND L P","reportingCik":null,"personType":"PN","sharesOwned":75200,"percentOfClass":1.87,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-001059","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"84841L407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"District 2 Capital LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-001059","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"84841L407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"District 2 Capital Fund LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-001059","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"84841L407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"District 2 Holdings LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-001059","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":"84841L407","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"District 2 GP LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001493152-26-007792","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, Par Value $0.0001 Per Share.","eventDate":"2026-02-19","reportingPerson":"PROEHL GERALD T","reportingCik":"0001279191","personType":"IN","sharesOwned":694687,"percentOfClass":17.3,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001172661-26-001308","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":53910,"percentOfClass":4.99,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001172661-26-001308","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":53910,"percentOfClass":4.99,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001172661-26-001248","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":53910,"percentOfClass":4.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001172661-26-001248","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":53910,"percentOfClass":4.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-000261","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Bigger Michael","reportingCik":null,"personType":"IN","sharesOwned":300103,"percentOfClass":9.89,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-000261","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"BIGGER CAPITAL FUND L P","reportingCik":null,"personType":"PN","sharesOwned":239103,"percentOfClass":7.88,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-000261","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Bigger Capital Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":239103,"percentOfClass":7.88,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-000261","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"District 2 Capital Fund LP","reportingCik":null,"personType":"PN","sharesOwned":61000,"percentOfClass":2.01,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-000261","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"District 2 Capital LP","reportingCik":null,"personType":"PN","sharesOwned":61000,"percentOfClass":2.01,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-000261","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"District 2 GP LLC","reportingCik":null,"personType":"OO","sharesOwned":61000,"percentOfClass":2.01,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-26-000261","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"District 2 Holdings LLC","reportingCik":null,"personType":"OO","sharesOwned":61000,"percentOfClass":2.01,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001493152-26-004801","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, Par Value $0.0001 Per Share.","eventDate":"2026-01-29","reportingPerson":"PROEHL GERALD T","reportingCik":"0001279191","personType":"IN","sharesOwned":694576,"percentOfClass":19.6,"filedAt":"2026-02-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001493152-26-000967","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, Par Value $0.0001 Per Share.","eventDate":"2025-12-23","reportingPerson":"PROEHL GERALD T","reportingCik":"0001279191","personType":"IN","sharesOwned":694530,"percentOfClass":24.7,"filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001493152-26-000967","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, Par Value $0.0001 Per Share.","eventDate":"2025-12-23","reportingPerson":"Proehl Investment Ventures LLC","reportingCik":"0001877913","personType":"IN","sharesOwned":79950,"percentOfClass":2.8,"filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001213900-26-000486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-12-24","reportingPerson":"Mitchell P. Kopin","reportingCik":null,"personType":"HC,IN","sharesOwned":147059,"percentOfClass":5.5,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001213900-26-000486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-12-24","reportingPerson":"Daniel B. Asher","reportingCik":null,"personType":"HC,IN","sharesOwned":147059,"percentOfClass":5.5,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0001213900-26-000486","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common stock, par value $0.0001 per share","eventDate":"2025-12-24","reportingPerson":"Intracoastal Capital LLC","reportingCik":null,"personType":"OO","sharesOwned":147059,"percentOfClass":5.5,"filedAt":"2026-01-02","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-25-003402","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-23","reportingPerson":"Bigger Michael","reportingCik":null,"personType":"IN","sharesOwned":197549,"percentOfClass":7.43,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-25-003402","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-23","reportingPerson":"District 2 Capital Fund LP","reportingCik":null,"personType":"PN","sharesOwned":122549,"percentOfClass":4.61,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-25-003402","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-23","reportingPerson":"District 2 Capital LP","reportingCik":null,"personType":"PN","sharesOwned":122549,"percentOfClass":4.61,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-25-003402","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-23","reportingPerson":"District 2 GP LLC","reportingCik":null,"personType":"OO","sharesOwned":122549,"percentOfClass":4.61,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-25-003402","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-23","reportingPerson":"District 2 Holdings LLC","reportingCik":null,"personType":"OO","sharesOwned":122549,"percentOfClass":4.61,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-25-003402","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-23","reportingPerson":"Bigger Capital Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":75000,"percentOfClass":2.82,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/drma"},{"accessionNo":"0000921895-25-003402","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001853816","issuerName":"Dermata Therapeutics, Inc.","ticker":"DRMA","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-23","reportingPerson":"BIGGER CAPITAL FUND L P","reportingCik":null,"personType":"PN","sharesOwned":75000,"percentOfClass":2.82,"filedAt":"2025-12-30","canonicalUrl":"https://xoomar.com/markets/stocks/drma"}],"updatedAt":"2026-11-03T22:36:51.953Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/drma","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}